Nocif Joseph Espat, MD

Assistant Dean

Nocif Espat
401.456.2000

Biography

Dr. Espat graduated from the University of Florida College of Medicine in 1990. Dr. Espat works in Providence, RI and specializes in Hematology/Oncology. Dr. Espat is affiliated with Roger Williams Medical Center.

Other Positions

  • Professor, Surgery, Boston University Chobanian & Avedisian School of Medicine

Education

  • University of Florida College of Medicine, MD
  • University of Illinois, MS
  • University of South Florida, BA

Publications

  • Published on 4/16/2025

    Jimenez M, Salehi O, Somasundar P, Dandeneau J, Chebl J, Vognar L, Espat NJ, Calvino AS, Kwon S. Impact of American College of Surgeons Geriatric Surgery Verification Program in Patients Undergoing Major Abdominal Oncologic Operation at a Cancer Center. J Am Coll Surg. 2025 May 01; 240(5):749-757. PMID: 39655814.

    Read at: PubMed
  • Published on 4/1/2025

    Stillman M, Somasundar P, Espat NJ, Calvino AS, Kwon S. ASO Visual Abstract: Negative Impact of Systemic Therapy on Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Low-Grade Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2025 Apr; 32(4):2949-2950. PMID: 39601937.

    Read at: PubMed
  • Published on 1/25/2025

    Sousa A, Al Masad Q, Pena P, Espat NJ, Calvino AS, Somasundar P, Abdelfattah T, Kwon S. Impact of immunotherapy on the care patterns and outcomes of patients with advanced hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2025 Mar; 49(3):102542. PMID: 39870347.

    Read at: PubMed
  • Published on 1/18/2025

    Ali MS, Ahn J, Espat NJ, Calvino AS, Koness J, Somasundar P, Kwon S. Disparities in utilization of novel cancer therapies in advanced stage III and IV melanoma and variance in outcomes. Immunotherapy. 2025 Jan; 17(1):37-46. PMID: 39825755.

    Read at: PubMed
  • Published on 1/16/2025

    Salehi O, Zhao I, Abi Chebl J, Somasundar P, Vognar L, Espat NJ, Calvino AS, Kwon S. Characteristics of older patients undergoing major oncological surgery: Insights from the Geriatric Surgery Verification Program. J Geriatr Oncol. 2025 Mar; 16(2):102189. PMID: 39818018.

    Read at: PubMed
  • Published on 1/3/2025

    Al Masad Q, Sousa A, Pena P, Sammartino CJ, Somasundar P, Abdelfattah T, Espat NJ, Calvino AS, Kwon S. Relationship of Time to First Therapy and Survival Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery Approach in Resectable Pancreatic Ductal Adenocarcinoma. J Surg Res. 2025 Feb; 306:111-121. PMID: 39754820.

    Read at: PubMed
  • Published on 12/2/2024

    Salehi O, Chandani KU, Sammartino CJ, Somasundar P, Espat NJ, Calvino AS, Kwon S. Impact of medicaid expansion on screenable versus non-screenable gastrointestinal cancers. J Cancer Policy. 2025 Mar; 43:100525. PMID: 39631725.

    Read at: PubMed
  • Published on 11/5/2024

    Stillman M, Somasundar P, Espat NJ, Calvino AS, Kwon S. Negative Impact of Systemic Therapy on Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Low-Grade Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2025 Jan; 32(1):221-229. PMID: 39500859.

    Read at: PubMed
  • Published on 2/7/2022

    Winkler CS, Hardaway JC, Ceyhan ME, Espat NJ, Saied Calvino A. Decreasing colorectal cancer screening disparities: A culturally tailored patient navigation program for Hispanic patients. Cancer. 2022 May 01; 128(9):1820-1825. PMID: 35128638.

    Read at: PubMed
  • Published on 4/1/2020

    Jeyarajah DR, Doyle MBM, Espat NJ, Hansen PD, Iannitti DA, Kim J, Thambi-Pillai T, Visser BC. Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm. J Gastrointest Oncol. 2020 Apr; 11(2):443-460. PMID: 32399284.

    Read at: PubMed

View 113 more publications: View full profile at BUMC

View all profiles